DNA damage is a critical factor in the initiation of chemically induced toxicities (including cancer), and the repair of this damage represents the cell's first line of defense against the deleterious effects of these agents. The various mechanisms of DNA repair are reviewed briefly and the actions of the DNA repair protein 06-alkylguanine-DNA alkyltransferase (ATase) are used to illustrate how DNA repair can protect cells against alkylating agent-induced toxicities, mutagenesis, clastogenesis, and carcinogenesis. The effectiveness of this repair protein can be measured based on its ability to deplete levels of its promutagenic substrate O 6 -methylguanine ( O 6 -meG) in the DNA of cells. These studies reveal that the repair of O 6 -meG from DNA occurs heterogeneously, both intra-and intercellularly. Even in cells that repair O 6 -meG hyperefficiently, certain regions of chromatin DNA are repaired with difficulty, and in other regions they are not repaired at all; most likely this lack of repair is a result of the location of the lesion in the DNA sequence. When individual cells are compared within a tissue, some cells are clearly repair deficient, because the O 6 -meG can persist in DNA for many weeks, whereas in other cells, it is removed within a matter of hours. The role of these repair-deficient cells as targets for alkylating agent-induced carcinogenesis is considered. The mechanisms of the homeostatic control of DNA repair function in mammalian cells are not yet well understood. Because there are now indications of the mechanisms by which the level of DNA damage may be sensed (and so influence the activity of the ATase repair protein), this is an important area for future study.
INTRODUCTION
It is generally accepted that DNA damage is a critical factor in the initiation of chemically induced cancer. The lesions that are introduced into DNA result from the action of chemicals that either enter the body from exogenous sources or are produced internally by endogenous mechanisms (33) . Tumors are usually generated by the carcinogen in a dose-dependent manner, but at the level of the specific target sites this is not always immediately apparent. This is a reflection of the heterogeneity of the carcinogen-induced responses inherent within the tissues; numerous factors are thus expected to combine to determine the events relevant for carcinogenesis in specific target cells. These include the cohort of enzymes responsible for the metabolism of carcinogens into their active intermediates, which determines the intrinsic level of DNA damage and, subsequently, the various DNA repair processes that represent the cell's first line of defense against the damage introduced into DNA as a result of carcinogen exposure. In this article, the roles played by DNA repair processes in the amelioration of DNA damage in relation to cell replication and the genesis of cancer are considered.
DNA REPAIR MECHANISMS DNA repair mechanisms subdivide into processes in which either the primary structure of DNA remains unaffected (ie, direct repair) or in which a &dquo;cutting and patching&dquo; process is involved (ie, indirect repair). These processes have been extensively reviewed (28, 40, 43) ; briefly, they are as follows. In the case of direct repair, the damage is simply reversed, as in the case of the photolyase that uncouples pyrimidine dimers or photoproducts that result from exposure to ultraviolet irradiation. The other example of this mode of repair is that of the 06-alkylguanine-DNA alkyltransferase (ATase), which specifically removes an alkyl group or other modifications from the 06-position of guanine, the 0-1-position of thymine, and from alkylphosphotriesters. In bacteria, 2 separate active sites in the same repair protein are responsible for the repair of the 3 lesions, but in mammalian cells, a separate uncharacterized process is involved in the repair of phosphotriesters. In principle, the ATase mechanism is error free. Three forms of indirect repair have been recognized. Base excision repair is characterized by a group of proteins that, in general, repair very specific lesions from DNA (39, 43) . The repair process commences with the recognition and release of the modified base by an Nglycosylase. The resulting apurinic (or apyrimidinic) (AP) site is then acted upon either by an inherent APlyase activity of the glycosylase or by an AP endonuclease. Following removal of the residual deoxyribose phosphate group, a 1-6 base patch is excised; this is then replaced using the opposite DNA strand as a template, and finally the strand is ligated to complete the repair. Nucleotide excision repair is a similar but more complex process, one that requires the recognition of a distortion in the DNA helix, which is usually caused by bulky lesions, rather than recognition of a single specific base modification (43) . For example, in the repair of cyclobutane pyrimidine dimers, one excision is made 5 or 6 phosphodiester bonds 3' to the lesion and another 22 to 24 phosphodiester bonds on the 5' side of the lesion, resulting in the excision of a fragment that is 27-32 nucleotides long; more extensive resynthesis is thus required before the DNA strand can be ligated to complete the repair.
These indirect repair processes are prone to error because of the potential for polymerase error and because replication takes place against a template that may also be damaged. Mismatch repair is another form of indirect excision repair that occurs when a mismatch results from polymerase slippage due to replication over a damaged template (28) . The process is specific in that certain mismatches are recognized (ie, all except C:C mispairs), and this is followed by an excision repair process.
These repair processes do not act in isolation but rather are controlled and are overlapping in specificity so as to provide the cell with an &dquo;umbrella&dquo; of protection against the various modifications to DNA that may be lethal, toxic, mutagenic, and hence potentially carcinogenic. Damage to DNA itself acts as a signal for the synthesis of certain proteins (eg, p53, p2l,lafl,&dquo;iP', and others) to initiate a complex controlling system that is responsible for the modulation of DNA damage and that determines whether a cell will abort via the apoptotic route or be repaired and survive (6, 10, 44) . As a consequence of the induction of lethal events, DNA damage may indirectly initiate cell replication in surviving cells to ensure tissue replacement. This action is in addition to the lower, but widespread, levels of DNA synthesis that occur as part of the repair process, as described above. The following account will consider damage introduced into DNA by the classical alkylating agents and will outline the subtle interactions between the various processes that take place at the level of individual target cells.
ALKYLATION AND REPAIR OF DNA
The alkylating agents introduce modifications into DNA, not at 1 but at some 13 sites, and in widely dif-fering relative amounts (26) . In the case of the methylating agents, the majority of the reaction occurs at the N7 position of guanine, but biologically this is much less harmful than a reaction at the 06-position of guanine and the 04-position of thymine, which occur at approximately 1/lOth and 1/100th of the reaction at the N7 atom of guanine, respectively (38) : both are potentially mutagenic, and in the case of the former, toxic as well (27) . These 2 modifications are repaired by the direct (ATase) mechanism, whereas methylations at the 7-and 3-atoms of purine and the 02 -atoms of thymine and cytosine are repaired by the indirect (base excision) mechanism. In ATase-deficient cells, 06-methylguanine (06 -meG) may also be repaired inefficiently by the nucleotide excision repair system (3) . When the ATase protein fails to repair 06-meG before cell replication occurs, anomalous base pairs can be generated, and these can be recognized by the mismatch repair system, resulting in a futile cycle of repair and resynthesis that is thought to be responsible for the lethal effects of 06-meG (19) . On the other hand, failure of the mismatch repair system can therefore result in heritable mutations.
The ATase protein is normally widely distributed throughout the tissues of the body, but higher levels of activity are found in liver and relatively low levels in tissues such as bone marrow and brain (14) . Use of polyclonal antibodies to the ATase protein has demonstrated that it is normally sequestered in the nucleus (24) , and only in certain pathological conditions [eg, advanced hepatitis B cirrhosis (23) or in colon tumor tissue (45) ] is it detected in significant amounts in the cytoplasm. The repair capacity of tumor cells is frequently reported to be lower than that of the corresponding normal cells (32) , but for the most part, and even in tumor tissue, the nuclear localization remains the same (20, 24) .
Expression of the protein is inducible, at least in some rodents, by a wide variety of agents. In general, these are DNA damaging agents (38) , and in mice, at least, a wildtype p53 genotype is required for full induction to occur. For example, X-irradiation did not induce ATase activity above the constitutive level in the livers of p53 null mice, but it did do so in the wild-type, and in the heterozygote, an intermediate level of induction was observed (35) .
Neither the constitutive expression nor induction of the ATase protein occurs uniformly in all the cells of a tissue. When 2-acetylaminofluorene is used to induce hepatic ATase in rats, a 5to 6-fold overall increase in functional activity is observed, which is accompanied by a corresponding increase in messenger RNA levels. When an immunohistochemical analysis is conducted (Figure 1 ), this indicates a higher level of constitutive expression in hepatocytes rather than in nonparenchymal cells, and the induction of the protein is also largely confined to the hepatocytes (7) . Such observations indicate that the measurement of ATase activity in whole-tissue extracts is much less informative than are methods that reveal interand intracellular distribution and modulation patterns.
REPAIR OF DNA BY THE ATASE MECHANISM

Cells with Differing ATase Thresholds
Cells with differing thresholds of ATase activity have been used both to explore the protective role of the pro- tein itself and to identify the biological importance of the substrate in DNA. For these purposes, cells that do not express the ATase protein, normal expressors, and genetically engineered cells capable of expressing artificially elevated levels of ATase protein have been used (27) . In a report that paved the way for many subsequent studies, Brennand and Margison (4) described the introduction of the Escherichia coli ada gene under the control of a retrovirus promoter into repair-deficient cells to create the mammalian cell equivalent of bacterial wild-type and mutant strains. Using similar constructs and those of the human ATase gene under the control of a metallothionein I gene promoter, it was shown in hemopoietic and other cell lines that while 7-methylguanine (7-meG) in DNA was relatively innocuous, 06-meG was indeed a toxic lesion, one that was also shown to be mutagenic and clastogenic because the repair of this lesion very effectively protected such cells against the deleterious effects of this DNA modification (25, 27) . Mice that are transgenic for either the bacterial protein or the human repair protein have since been shown to protect very effectively against nitrosocompound-induced tumors of the liver (30) or thymus (9) .
Collectively these studies show how this DNA repair system provides a comprehensive level of protection against the deleterious effects of alkylation damage to DNA. As indicated, this system does not act in isolation but rather concomitantly with the processes of base excision and nucleotide excision repair, which will be active against the other base modifications and the apurinic/ apyrimidinic sites generated by these enzymes or resulting from the spontaneous cleavage of the glycosidic bonds to ensure that the DNA is restored to its normal, predamaged state.
Kinetics of Repair
While the direct in vitro assay of functional activity may indicate the potential efficiency of action of the ATase protein, in vivo repair efficiency can only be assessed by the rate at which its substrate, 06-meG, is removed from the DNA of cells. In contrast to the situation in ATase-deficient cells, in which 06-meG persists for a long time, in tissues expressing the constitutive level of ATase, the repair of 06-meG from DNA approximates initially to a first-order reaction, but eventually a basal level of the lesion persists. Even in ATase-hyperexpressing cells, in which the repair of 06-meG is very rapid (such as in the transfected cells discussed above), a low basal level of 06-meG remains. The interpretation of these observations is thus a critical issue in understanding the role of promutagenic lesions, such as 06-meG, within the cell.
This issue has been addressed in several ways. In one study (37) , the persistence of 7-meG and 06 -meG were followed in the hepatic chromatin DNA of rats given a single dose of N-nitrosodimethylamine (NDMA; 2 mg/ kg intraperitoneally). Over a period of 30 hours, the 7-meG concentrations declined in a relatively uniform manner (tl/2 -20 hours) regardless of whether the analysis was for total DNA or for various chromatin DNA fractions. The concentration of 06-meG, however, was reduced much faster and at different rates in certain chromatin fractions. In total DNA and in the &dquo;bulk&dquo; DNA (>90% of the chromatin DNA), the half-life was -9
hours; in the rapidly transcribed fraction it was <5 hours, but the half-life was -16 hours in the nuclear matrix fraction (<5% of chromatin DNA), in which DNA is anchored to the nuclear skeleton and is undergoing replication. In cultured cells, ATase has recently been shown to locate to actively transcribing sites in DNA to provide an effective means of ensuring the repair of promutagenic lesions (1) . When ATase activity was induced by administering NDMA (15 j..Lg/ml) in the drinking water for 4 weeks prior to the subsequent administration of the single dose of NDMA (2 mg/kg), the rate of removal of 06-meG (but not 7-meG) was accelerated, and the differential in the removal of 06-meG from the chromatin fractions was maintained (37) . The localization and repair of 06 -meG in these chromatin subfractions was also examined in ATase-deficient RJKO cells and in the same cell line harboring the entire coding sequence of the E. coli ada gene housed in a retrovirus-based mammalian expression vector (5) . Parallel cultures of cells transfected with vector alone or with vector containing the ada gene were exposed for 1 hour to N-methylnitrosourea (NMU; 0.17 mM). In the control, ATase-deficient cells (<2 fmoles ATase/mg protein), the slow repair of 06-meG from total genomic DNA was observed over 21 hours in all the chromatin fractions, except in the case of the nuclear matrix fraction, in which little repair was evident ( Table 1 ). In the overexpressing cells (>2,000 fmoles ATase/mg protein), the repair of 06-meG was so efficient that at the zero time (ie, after 1 hour of exposure to NMU), the initial level of 06-meG was only 2-3 >moles/mole G, compared with w-30 {jbmoles/mole G in the control cells. Over the 21-hour period of observation, further repair of O~-meG-to a level <2 >mole/mole G-occurred in the ATase-proficient cells, except again in the case of the nuclear matrix fraction, in which the concentration of 06-meG remained above that for the zero time for the total genomic DNA ( Table 1) . It is evident from this study and from the previous in vivo observations that the repair of 06_meG is much less efficient in this nuclear matrix-associated DNA fraction (E C. R. Manning, G. P. Margison, P J. O'Connor, and
M. A. Billett, unpublished observations).
A more detailed study of the kinetics of 06-meG repair was also conducted in these 2 cell lines using a study period of 120 hours but using only total genomic DNA.
The removal of 06_meG from the DNA of both cell lines followed first-order kinetics (Figure 2 ), and as in the previous experiment, it fell to a basal level-in this case, it fell to -3 and <1 1 ~.moleslmole G, respectively, in the repair-deficient and repair-proficient cell lines (Figure 2 ). After this period of in vivo repair, the DNA containing the residual amounts of 06-meG was isolated and exposed to large excesses (10to 100-fold) of recombinant ada ATase protein, and as indicated in Table 2 , the protein was unable to repair all of the 06-meG that was present, even after 2 further rounds of isolation and exposure of the DNA to these large excesses of the recombinant protein. It is therefore evident that when in vivo repair is complete (ie, after 120 hours), some 10% of the initial 06-meG remains unrepaired, and of this 10%, a FIGURE 2.-The repair of 06-meG from total chromatin DNA of repair-deficient V79 Chinese hamster lung fibroblasts (Clone 6E) and the same V79 cells harboring the E. coli ada gene (Clone 8). Cells were exposed to NMU (0.17 mM) for 1 hour and were then incubated in serum-free medium for periods of up to 120 hours in order to permit the repair of 06-meG from DNA. Samples were taken at intervals, and cell lysates were assayed for ATase activity using a 3H-NMU-methylated DNA substrate (29) ; DNA was also extracted from the harvested cells (37) for determination of the 06-meG concentration by radioimmunoassay (42) after chromatographic concentration of the methylated base (34) . Where shown, the error bars indicate standard deviations for assays made in triplicate. Billett, unpublished observations). Support for the latter conclusion comes from studies of 06-meG located in codon 12 of H-ras. When 06-meG is in position 2 of codon 12, it is repaired very inefficiently by the E. coli ada protein, and it is also much less accessible to an antibody to 06 -meG; both of these effects are dependent upon the flanking sequences of the modified guanine and provide a reasonable explanation for the high frequency of mutations caused by lesions at this site in the gene (13) .
Based on these studies, it appears that 06-meG in in vivo DNA exists in at least 3 different categories-namely, that which is easily repaired, that which is repaired with difficulty because of the protective effect of chromatin proteins, and that which is virtually unrepairable (most likely because of the location of the residue within the DNA sequence).
In Vivo Repair
Although promutagenic lesions that are not easily repaired in certain sequences of DNA have clear implications for the mutability of individual cells, when the kinetics of repair from whole-tissue DNA is examined, the gross residual levels of 06-meG are more likely to be attributable to cell heterogeneity and thereby to the presence of cells that are ATase deficient. Studies that illustrate these latter events can be approached immunohistochemically using antibodies to 06-meG (31) so that the nuclear location of the modified base can be observed and its persistence followed with time. Such studies clearly demonstrate the heterogeneity of cells within tissues, both with respect to their ability to metabolize alkylating agents to their biologically relevant alkylating intermediates (which produce 06-meG and other lesions in DNA) and with respect to their capacity for the repair of this base from nuclear DNA.
When rats are given a single dose of NDMA, immunohistochemical analysis of liver lobules in sections from animals sampled 5 hours later shows that nuclei containing 06-meG are distributed centrilobularly and that with high doses (eg, those approaching the dose that is lethal to 50% of test subjects), only the hepatic nuclei of the portal zone apparently remain unalkylated (8) . The distribution of nuclei containing 06-meG corresponds closely with the centrilobular distribution of cells expressing CYP2EI, the demethylase protein responsible for the metabolic activation of NDMA (16) . However, if rats are maintained on a protein-deficient diet, this reduces the capacity for the hepatic metabolism of NDMA (41) , and the width of the zone of 06-meG containing nuclei around the hepatic central veins narrows dramatically (11) . This reduced consumption of the nitrosamine allows more to remain in circulation and so exposes other, moresensitive organs to the carcinogen. Thus, when weanling rats are given a protein-deficient diet, they become much more sensitive to the induction of renal tumors by a single dose of NDMA than do the normally fed controls (15) . Examination of renal sections from these animals shows that the nuclei of many cells within the cortex are alkylated, notably those of the proximal tubules, the mesenchymal interstitial cells, and the cells of the capsule of Bowman; cells within the capsule of Bowman and those of the medulla, however, apparently remain unaffected (11) . Within a few days, most of the 06 -meG has been repaired from the cells of the renal cortex, with the exception of the mesenchymal cells, which, for the most part, remain heavily alkylated. Such cells are therefore identified as being metabolically competent and repair deficient and are in fact the cells recognized previously by Hard and Butler (15) as the target cells in this model for renal neoplasia. Use of an antibody to bromodeoxyuridine (BrdU) on sections from animals given BrdU in the drinking water shows that this is also a slowly replicating cell population, and as such, this population has all the required characteristics of target cells (ie, replication over a damaged template either before the action of or in the absence of an efficient repair mechanism). Some 10 weeks after the initial dose of NDMA, when the animals have grown to maturity, DNA repair-deficient mesenchymal cells can be readily identified as cells with nuclei that still stain strongly for 06-meG. At this time, small foci of mesenchymal cells are developing, as determined from the incorporation of BrdU. After a further 10 weeks, mesenchymal cell tumors are ramifying among the proximal tubules of the renal cortex (12) .
In a similar way, target cells have also been identified in the large bowel of Swiss mice using a protocol in which weekly injections of 1,2-dimethylhydrazine are used to induce adenocarcinomas (17, 36) . In this system, cells of the regenerative regions of the bowel crypt were shown to be alkylated, whereas in the small intestine, where no tumors were produced, alkylation damage to DNA was confined to the villi in the end cells that were shortly to be exfoliated (R E. Jackson, P J. O' Connor, and A. C. Povey, unpublished observations). An extensive study of cancer induced in the rat stomach by Nmethyl-M-nitro-N-nitrosoguanidine (MNNG) (46) also produced similar conclusions. In the forestomach, squamous cell papillomas and carcinomas were induced by single doses of MNNG, which alkylated virtually all the cells of the squamous epithelium and which also caused a 3to 5-fold increase in the proliferation of these cells before the repair of 06-meG could be completed (47) . In the pylorus of animals given these single doses of MNNG, only the upper parts of the gastric glands were alkylated, but after receiving a chronic dose via the drinking water, the glands increased in length, and the zone of replication extended upward to overlap with the region of the gland where the cells were alkylated (48) . Again, this created a situation in which alkylated cells were replicated before their DNA could be effectively repaired.
It is evident from these studies that the efficient repair of DNA can effectively protect cells from the deleterious biological effects of alkylating agents, including the generation of tumors. This is illustrated most clearly in the situation in which, via gene transfer methods, overexpression of the repair protein has been achieved, but it is also evident in the opposite situation, in which cells are either repair deficient (eg, in the NDMA renal tumor model), or when alkylation occurs in cells that are about to replicate, so that the repair process does not have the time to act (eg, the murine bowel or the rat stomach after treatment with 1,2-dimethylhydrazine or MNNG, respectively). It is clear from studies in animal models that repair proteins such as ATase can be induced, but in the human population, in which cells are more usually exposed to low levels of carcinogens rather than to sporadic high exposures, there is also evidence that threshold levels of repair proteins are maintained in some sort of balance in relation to the level of DNA damage. In the blad-der DNA of patients with bilharzial cancer, for example, an inverse relationship was observed between the 06-meG concentration and the constitutive level of ATase activity (2) . An inverse correlation was also seen between the level of 06-meG in the peripheral lymphocyte DNA of patients given therapeutic doses of DTIC or 1-p-carboxy-3,3-dimethylphenyltriazene and the pretreatment levels of ATase activity in the same cell population (21, 22) . In carcinogenicity studies, an inverse relationship has also been observed between the level of expression of ATase in the normal human colon and the frequency of GC:AT transition mutations in the K-ras protooncogene of colorectal tumors (18) . The extent to which repair capacity thresholds are regulated in relation to environmental exposures, however, awaits further elucidation. These observations are of general relevance not only in terms of the process of carcinogenesis but also in terms of the effects of alkylating agents used in chemotherapy and the generation of tumor resistance.
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